TPW
ABBV icon

Transatlantique Private Wealth’s AbbVie ABBV Stock Holding History

Transatlantique Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.37M Buy
6,175
+920
+18% +$210K 0.43% 69
2025
Q3 		$1.22M Buy
5,255
+812
+18% +$165K 0.4% 73
2025
Q2 		$825K Buy
4,443
+138
+3% +$25.6K 0.3% 97
2025
Q1 		$902K Sell
4,305
-122
-3% -$23.7K 0.36% 84
2024
Q4 		$787K Sell
4,427
-236
-5% -$43.4K 0.3% 98
2024
Q3 		$921K Sell
4,663
-264
-5% -$49.3K 0.35% 84
2024
Q2 		$840K Sell
4,927
-348
-7% -$57.6K 0.34% 80
2024
Q1 		$961K Sell
5,275
-122
-2% -$21K 0.42% 79
2023
Q4 		$836K Sell
5,397
-470
-8% -$68.5K 0.39% 84
2023
Q3 		$875K Hold
5,867
– – 0.47% 73
2023
Q2 		$790K Sell
5,867
-366
-6% -$53.7K 0.41% 84
2023
Q1 		$993K Buy
6,233
+90
+1% +$13.8K 0.55% 52
2022
Q4 		$996K Sell
6,143
-60
-1% -$9.2K 0.6% 52
2022
Q3 		$833K Sell
6,203
-1,944
-24% -$279K 0.56% 56
2022
Q2 		$1.25M Buy
+8,147
New +$1.24M 0.87% 28

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Transatlantique Private Wealth's ABBV Position: Q4 2025 in Review

Transatlantique Private Wealth increased its AbbVie (ABBV) stake by 18% in Q4 2025, buying an estimated $210K and bringing the position to 6,175 shares worth $1.37M. The position accounts for 0.43% of the portfolio, ranked #69.

Transatlantique Private Wealth first reported a position in ABBV in Q2 2022 and has held it in 15 quarters since. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • Transatlantique Private Wealth held 6,175 shares of AbbVie worth $1.37M as of Q4 2025.
  • Transatlantique Private Wealth bought 920 AbbVie shares in Q4 2025, an estimated $210K.
  • AbbVie made up 0.43% of Transatlantique Private Wealth's portfolio in Q4 2025, its #69 holding.
  • Transatlantique Private Wealth first reported a position in AbbVie in Q2 2022 and has held it in 15 quarters since.
  • 4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.